Case studies show five people who found better treatments for neuropsychiatric symptoms from data collected while patients were at home.
Check out the latest news from CURE and beyond for clinicians and researchers in the field of epilepsy.
Genetics
The authors conclude that the gene should be removed from commercial genetic testing panels to reduce the burden of mutations of uncertain significance for healthcare providers, families, and patients with epilepsy.
Plus, a pediatric-focused webinar, new tax benefits when you donate, and more.
In Norway, researchers state that discontinuation of drug treatment in patients with long-term seizure freedom is discussed far too seldom and that many patients may be living with an unnecessary drug burden.
Researcher explore the underlying causes of epilepsy in older people, difficulties in establishing a diagnosis of epilepsy in this population, appropriate antiseizure medications, and potential surgical treatment options.
The uninsured and people residing outside of the Northeast were less likely to see an epilepsy provider, and people living in poverty were less likely to use medications, relative to their comparison groups, according to this report.
According to this study, neither the virus nor potential risk factors for seizures seem to be significant risks for the occurrence of acute symptomatic seizures in COVID?19.
Metabolic syndrome is seen in more than half of people with epilepsy, and this increased prevalence is not associated with the number of antiepileptic medicines, according to this study.
